Clinical Timeline
Marcus Aldridge · MRN-004821 · Chronological record of clinical events
Office Visit — Diabetes/HTN Follow-upCompletedDM2HTNCKD
HbA1c 8.4% — SGLT2 inhibitor initiated. Nephrology referral placed.
May 28, 2026
10:15 AM
Author: Dr. Chen·Source: Progress Note
Metabolic Panel + HbA1cReviewed
HbA1c: 8.4% ↑ | Creatinine: 1.8 ↑ | eGFR: 44 ↓ | Cholesterol: 214 ↑
May 28, 2026
8:30 AM
Author: Quest Diagnostics·Source: Lab Result — May 28
Empagliflozin 10mg — New PrescriptionActive
Initiated for glycemic control with renoprotective benefit. Monitor for UTI symptoms.
May 28, 2026
11:00 AM
Author: Dr. Chen·Source: e-Prescription
Office Visit — Routine Follow-upCompletedDM2HTN
HbA1c 7.9%. BP partially controlled. Dietary counseling reinforced.
Apr 15, 2026
9:30 AM
Author: Dr. Chen·Source: Progress Note
AI Chart Summary — GeneratedDraft
3-visit trend: HbA1c improving (8.8 → 7.9 → 8.4 — recent uptick). BP above target. CKD progression risk elevated. Care gaps: ophthalmology annual exam overdue.
AI-generated summary for workflow support only. Not a medical diagnosis. Verify with primary source documents.
Jun 1, 2026
12:00 AM
Author: Chart Assistant·Source: AI Summary
Care Plan Update — Nephrology ReferralPending
Referral submitted to Nephrology Associates. Priority: Stage 3a CKD with diabetic etiology. Appointment requested within 30 days.
May 28, 2026
11:30 AM
Author: Dr. Chen·Source: Care Plan
End of loaded timeline — 6 events shown. Load earlier records…